Overcoming Imatinib resistance using CAI, a calcium-mediated signal transduction inhibitor: A new therapeutic strategy for chronic myelogenous leucemia
Autori: Corrado,C; Fontana, S,; Giordano, M; Colomba, P; Raimondo, S; Arlinghaus, RB; Kohn, EC; De Leo, G; Alessandro, R
Anno di pubblicazione: 2008
Tipologia:
Proceedings
Parole Chiave: Imatinib resistance; carboxyamdotriazole; Chronic Myelogenous Leukemia
